Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study
Fahad Faqihi, Abdulrahman Alharthy, Mohammed A. Al-Odat, et al.
Journal of Critical Care (2020) Vol. 60, pp. 328-333
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study
Abdulrahman Alharthy, Waleed Aletreby, Fahad Faqihi, et al.
Journal of Epidemiology and Global Health (2020) Vol. 11, Iss. 1, pp. 98-98
Open Access | Times Cited: 127
Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial
Fahad Faqihi, Abdulrahman Alharthy, Salman Abdulaziz, et al.
International Journal of Antimicrobial Agents (2021) Vol. 57, Iss. 5, pp. 106334-106334
Open Access | Times Cited: 81
Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: A case‐series
Abdulrahman Alharthy, Fahad Faqihi, Ziad A. Memish, et al.
Artificial Organs (2020) Vol. 45, Iss. 5
Open Access | Times Cited: 75
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome
Mickael Beraud, Sabria Al Hashami, Miquel Lozano, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 4, pp. 103433-103433
Open Access | Times Cited: 29
Residual Lung Injury in Patients Recovering From COVID‐19 Critical Illness
Abdulrahman Alharthy, Mohamed Abuhamdah, Abdullah Balhamar, et al.
Journal of Ultrasound in Medicine (2020) Vol. 40, Iss. 9, pp. 1823-1838
Closed Access | Times Cited: 48
Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review
Lubna I. Abu-Rub, Hana A. Abdelrahman, Al-Reem A. Johar, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 935-935
Open Access | Times Cited: 37
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
Isabelle Amigues, Alexander H. Pearlman, Aarat Patel, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1185-1204
Open Access | Times Cited: 33
Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proof
Sara I. Aboras, Ahmed A. Megahed, Fawzy A. El‐Yazbi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices
Gopal Kumar Patidar, Kevin J. Land, Hans Vrielink, et al.
Vox Sanguinis (2021) Vol. 116, Iss. 7, pp. 798-807
Open Access | Times Cited: 24
Prevalence of peripheral neuropathy and myopathy in patients post‐COVID‐19 infection
Dalia S. Saif, Reda Ibrahem, Mohamed Ahmed Eltabl
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 11, pp. 1246-1253
Open Access | Times Cited: 16
Impact of plasmapheresis on severe COVID-19
Gandhy Thomas Fonseca-González, Mario Eduardo Alamilla Sanchez, Vanessa García-Macas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
Fahad Faqihi, Abdulrahman Alharthy, Ziad A. Memish, et al.
Clinical Case Reports (2020) Vol. 8, Iss. 12, pp. 3233-3238
Open Access | Times Cited: 26
Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives
Ziad A. Memish, Fahad Faqihi, Abdulrahman Alharthy, et al.
International Journal of Antimicrobial Agents (2020) Vol. 57, Iss. 2, pp. 106273-106273
Open Access | Times Cited: 21
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence
Wen Lu, Walter E. Kelley, Deanna C. Fang, et al.
Journal of Clinical Apheresis (2021) Vol. 36, Iss. 3, pp. 483-491
Open Access | Times Cited: 19
Effect of time and titer in convalescent plasma therapy for COVID-19
Paola de Candia, Francesco Prattichizzo, S. Garavelli, et al.
iScience (2021) Vol. 24, Iss. 8, pp. 102898-102898
Open Access | Times Cited: 18
Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
Shunyao Chen, Cong Zhang, Deng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: A case series
Abdulrahman Alharthy, Fahad Faqihi, Abdullah Balhamar, et al.
SAGE Open Medical Case Reports (2020) Vol. 8
Open Access | Times Cited: 19
COVID-19 in a patient with a flare of systemic lupus erythematosus: A rare case-report
Abdulrahman Alharthy, Fahad Faqihi, Nasir Nasim, et al.
Respiratory Medicine Case Reports (2020) Vol. 31, pp. 101252-101252
Open Access | Times Cited: 19
What Is the Role of Therapeutic Plasma Exchange as an Adjunctive Treatment in Severe COVID-19: A Systematic Review
Łukasz J. Krzych, Zbigniew Putowski, Marcelina Czok, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1484-1484
Open Access | Times Cited: 17
The Impact of Therapeutic Plasma Exchange on Inflammatory Markers and Acute Phase Reactants in Patients with Severe SARS-CoV-2 Infection
Tamara Mirela Porosnicu, Ioan Ovidiu Sîrbu, Cristian Oancea, et al.
Medicina (2023) Vol. 59, Iss. 5, pp. 867-867
Open Access | Times Cited: 6
Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports
Abdulrahman Alharthy, Abdullah Balhamar, Fahad Faqihi, et al.
Respiratory Medicine Case Reports (2020) Vol. 31, pp. 101186-101186
Open Access | Times Cited: 16
The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19
Jing Guo, Xia He, Shuting Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 15
Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management
Shunyao Chen, Cong Zhang, Jialiu Luo, et al.
Inflammation Research (2024) Vol. 73, Iss. 12, pp. 2179-2197
Closed Access | Times Cited: 1
Thrombolysis in severe COVID-19 pneumonia with massive pulmonary embolism
Abdulrahman Alharthy, Fahad Faqihi, John Papanikolaou, et al.
The American Journal of Emergency Medicine (2020) Vol. 41, pp. 261.e1-261.e3
Open Access | Times Cited: 13
COVID-19 with spontaneous pneumothorax, pneumomediastinum, and subcutaneous emphysema in the intensive care unit: Two case reports
Abdulrahman Alharthy, Gultakin Bakirova, Homaida Bakheet, et al.
Journal of Infection and Public Health (2020) Vol. 14, Iss. 3, pp. 290-292
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top